Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) released topline data on Wednesday from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with ...

Washington, DC – November 7, 2025: The International Monetary Fund (IMF), on behalf of the Inter-Agency Group on Economic and Financial Statistics (IAG) and the Financial Stability Board (FSB), has ...

A $15-billion data center campus planned for Port Washington, Wis., is expected to surpass in size and cost a Microsoft Data Center being built in Mount Pleasant Wis. November 3, 2025 OpenAI, Oracle ...

TL;DR: Get a lifetime license to Microsoft Visio Professional 2021 for Windows for just $14.97 (MSRP $249.99) and bring clarity to complex data with powerful templates, shapes, and collaboration tools ...

The public will get a chance to provide input to regulators on a Lancaster city data center's proposed second phase, a two-story building expected to total 735,128 square feet and cost as much as $2.5 ...

Plans for new AI data center in Ector County reach next phase. Sharon AI and New Era Energy & Digital announced their flagship Texas Critical Data Center planned for Ector County has entered its ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Learn more about: Vantage Data Centers Plans for a major data ...

Donald Trump had many priorities upon returning to the Presidency, and one of the most pressing was to get Winston Churchill back into the Oval Office. A bust of Britain’s wartime Prime Minister, of ...

In a quarterly filing disclosed Thursday, Meta said it approved a plan in June to sell certain data center assets, reclassifying $2.04 billion worth of land and construction-in-progress as ...

Celcuity's phase 3 VIKTORIA-1 trial showed that gedatolisib significantly improved progression-free survival in PIK3CA wild-type HR+/HER2-advanced breast cancer patients. NDA submission for ...

Obefazimod’s strong Phase 3 induction data positions Abivax as a leading UC contender, with a novel mechanism and favorable safety profile. The ABTECT program’s robust design and inclusion of ...